Corvus Pharmaceuticals Inc buy Jefferies Financial Group Inc.
Start price
22.01.26
/
50%
€21.55
Target price
22.01.27
-
Performance (%)
-1.39%
Price
22.01.26
€21.25
Summary
This prediction is currently active. With a performance of -1.39%, the BUY prediction for Corvus Pharmaceuticals Inc by Jefferies_Financial_ is down slightly. This prediction currently runs until 22.01.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Corvus Pharmaceuticals Inc | -1.39% |
| iShares Core DAX® | -1.764% |
| iShares Nasdaq 100 | -1.632% |
| iShares Nikkei 225® | -2.451% |
| iShares S&P 500 | -2.252% |
Comments by Jefferies_Financial_ for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for CRVS provided by MarketBeat